Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan
· Delayed Price · Currency is TWD 367.00
-6.50 (-1.74%)
At close: Dec 5, 2025
Pell Bio-Med Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -373.72 | -389.42 | -398.76 | -230.13 | -188.96 |
| Depreciation & Amortization | 47.22 | 46.28 | 45.4 | 30.38 | 29.28 |
| Other Amortization | 0.19 | 0.6 | 0.22 | 0.66 | 0.88 |
| Loss (Gain) From Sale of Assets | - | 0.14 | 0.13 | - | 0.2 |
| Loss (Gain) From Sale of Investments | -4.61 | 0.62 | - | - | - |
| Loss (Gain) on Equity Investments | 0.03 | -0.11 | -0.11 | 0 | -0.01 |
| Stock-Based Compensation | 13.45 | 58.97 | 143.06 | 46.68 | 24.96 |
| Provision & Write-off of Bad Debts | - | - | - | 0.07 | - |
| Other Operating Activities | -15.98 | -6.8 | -2.98 | -1.15 | - |
| Change in Accounts Receivable | -2.91 | 3.85 | -1.56 | -1.62 | -3.39 |
| Change in Inventory | 0.03 | -2.42 | 0.82 | -0.34 | 7.15 |
| Change in Accounts Payable | 1.3 | -2.53 | 1.42 | 2.42 | -5.07 |
| Change in Unearned Revenue | - | - | - | -0.75 | - |
| Change in Other Net Operating Assets | 66.36 | 30.69 | 32.37 | -7.2 | 27.13 |
| Operating Cash Flow | -268.64 | -260.12 | -179.99 | -160.98 | -107.84 |
| Capital Expenditures | -303.12 | -263.79 | -16.49 | -6.5 | -14.48 |
| Sale of Property, Plant & Equipment | - | 1 | 3.49 | - | 0.05 |
| Sale (Purchase) of Intangibles | -0.41 | -0.19 | - | -2 | - |
| Investment in Securities | -56.74 | 228.72 | -402.15 | -536 | 100 |
| Other Investing Activities | -22.42 | -61.25 | -4.49 | -6.46 | -1.67 |
| Investing Cash Flow | -382.69 | -95.51 | -419.63 | -550.96 | 83.9 |
| Short-Term Debt Issued | - | 200 | - | 5 | - |
| Total Debt Issued | 200 | 200 | - | 5 | - |
| Short-Term Debt Repaid | - | - | -5 | - | - |
| Long-Term Debt Repaid | - | -25.65 | -25.07 | -10.76 | -10.26 |
| Total Debt Repaid | -127.45 | -25.65 | -30.07 | -10.76 | -10.26 |
| Net Debt Issued (Repaid) | 72.55 | 174.35 | -30.07 | -5.76 | -10.26 |
| Issuance of Common Stock | 19.1 | 331.17 | 625.77 | 759.34 | 5.02 |
| Repurchase of Common Stock | - | - | -0.8 | - | - |
| Other Financing Activities | 212.64 | 109.8 | - | 14.99 | - |
| Financing Cash Flow | 304.29 | 615.32 | 594.89 | 768.56 | -5.23 |
| Net Cash Flow | -347.03 | 259.69 | -4.73 | 56.62 | -29.17 |
| Free Cash Flow | -571.76 | -523.91 | -196.48 | -167.48 | -122.32 |
| Free Cash Flow Margin | -1906.30% | -2668.77% | -1089.53% | -976.14% | -875.12% |
| Free Cash Flow Per Share | -9.76 | -9.18 | -4.25 | -4.27 | -3.68 |
| Cash Interest Paid | 4.93 | 2.26 | 2.56 | 1.36 | 1.52 |
| Cash Income Tax Paid | 0.72 | 1.2 | 0.5 | 0 | - |
| Levered Free Cash Flow | -631.3 | -388.73 | -53.62 | -86.4 | - |
| Unlevered Free Cash Flow | -628.22 | -387.32 | -52.02 | -85.55 | - |
| Change in Working Capital | 64.77 | 29.6 | 33.05 | -7.49 | 25.81 |
Source: S&P Capital IQ. Standard template. Financial Sources.